Sign In/ Sign Up
Cipla's inhalable insulin fails to get approval for trials on Indian patients
Dec 6, 2016
Drug maker Cipla’s plan of developing a pump-delivered inhalable form of insulin has suffered a setback with an expert committee denying it permission to conduct trials on Indian patients. The panel has said the company’s preliminary data on safety and efficacy of the trial drug is insufficient....
Cipla’s inhalable insulin fails to get approval for trials on Indian patients
Cipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was being marked by Pfizer.
3 others like